Quantum BioPharma Ltd. Acquires GameStop Shares in Strategic Move Against Market Manipulation
July 22nd, 2025 1:25 PM
By: Newsworthy Staff
Quantum BioPharma Ltd. has purchased GameStop shares as part of its campaign against market corruption, alongside advancing its neurodegenerative therapies and settling debts.
Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company specializing in neurodegenerative therapies, has strategically acquired 2,000 shares of GameStop Corp. (NYSE: GME) to bolster its campaign against market manipulation. This investment aligns with the company's broader efforts to challenge corrupt trading practices, as evidenced by its legal pursuit of over $700 million in damages for alleged stock manipulation. Quantum BioPharma's initiatives, including the Lucid-MS program and contingent value rights linked to litigation outcomes, underscore its commitment to building value and integrity in the market. The company has also addressed its financial obligations by settling debts through the issuance of Class B shares.
Source Statement
This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,
